Premium
Freeform inkjet printing of cellular structures with bifurcations
Author(s) -
Christensen Kyle,
Xu Changxue,
Chai Wenxuan,
Zhang Zhengyi,
Fu Jianzhong,
Huang Yong
Publication year - 2015
Publication title -
biotechnology and bioengineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.136
H-Index - 189
eISSN - 1097-0290
pISSN - 0006-3592
DOI - 10.1002/bit.25501
Subject(s) - fabrication , layer (electronics) , axial symmetry , materials science , 3d printing , planar , nanotechnology , inkjet printing , biomedical engineering , inkwell , composite material , computer science , engineering , structural engineering , computer graphics (images) , medicine , alternative medicine , pathology
Organ printing offers a great potential for the freeform layer‐by‐layer fabrication of three‐dimensional (3D) living organs using cellular spheroids or bioinks as building blocks. Vascularization is often identified as a main technological barrier for building 3D organs. As such, the fabrication of 3D biological vascular trees is of great importance for the overall feasibility of the envisioned organ printing approach. In this study, vascular‐like cellular structures are fabricated using a liquid support‐based inkjet printing approach, which utilizes a calcium chloride solution as both a cross‐linking agent and support material. This solution enables the freeform printing of spanning and overhang features by providing a buoyant force. A heuristic approach is implemented to compensate for the axially‐varying deformation of horizontal tubular structures to achieve a uniform diameter along their axial directions. Vascular‐like structures with both horizontal and vertical bifurcations have been successfully printed from sodium alginate only as well as mouse fibroblast‐based alginate bioinks. The post‐printing fibroblast cell viability of printed cellular tubes was found to be above 90% even after a 24 h incubation, considering the control effect. Biotechnol. Bioeng. 2015;112: 1047–1055. © 2014 Wiley Periodicals, Inc.